
HD-RSC
News & Events
-
June 25, 2023 - June 29, 2023
DIA 2023 Global Annual Meeting | ILLUMINATE
The DIA 2023 Global Annual Meeting invites industry, regulatory government, academics, and patients to network, problem-solve, and discuss global and local challenges facing the life sciences community. Hosted in Boston, key C-Path personnel will be on-hand to discuss and view the many different perspectives offered at this event, while highlights expertise across the globe to...... -
April 27, 2023
View Now | Clinical Outcome Assessments: Does one size fit all?
Join C-Path’s Rare Disease Cures Accelerator-Data and Analytics Platform and its Rare Disease Clinical Outcome Assessment Consortium executive leaders Alexandre Betourne and Lindsey Murray for this new webinar Clinical Outcome Assessments: Does one size fit all? The webinar will cover: The complexity of identifying appropriate clinical outcome assessments for rare disease clinical trials An overview of the Rare...... -
October 25, 2022 - October 27, 2022
2022 C-Path Neuroscience Annual Meeting
C-Path’s Neuroscience Program (CPAD, CPP, CP-RND, CPTA, D-RSC, HD-RSC) is pleased to host the 2022 C-Path Neuroscience Annual Meeting, October 25-27, 2022 at The Westin Crystal City Reagan National Airport in Arlington, VA. The 2022 C-Path Neuroscience Annual Meeting will bring together global industry, academic and regulatory agency partners, colleagues and collaborators for an engaging,...... -
August 17, 2021
View Now | C-Path Neuroscience Program Webinar – NfL in Neurodegenerative Diseases
C-Path’s Neuroscience Program hosted its first webinar on August 17, 2021. This webinar brought together more than 330 members, representatives and partners from pharmaceutical industries, academic experts, government and regulatory agencies, and patient advocacy groups.
-
April 30, 2019
Huntington’s Disease Regulatory Science Consortium (HD-RSC) Inaugural Meeting Summary
Introduction Huntington’s Disease Regulatory Science Consortium (HD-RSC) Inaugural Meeting Summary April 29 & 30, 2019 – Rockville, Maryland The Huntington’s Disease Regulatory Science Consortium (HD-RSC), created in partnership with the CHDI Foundation and the Critical Path Institute (C-Path), was formally launched on March 28, 2018 with the primary goal of defining the regulatory science needs in order......